MIMEDX to Present at Upcoming Investor Conferences
10 Novembro 2022 - 10:00AM
MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a
transformational placental biologics company, today announced that
senior management will present at the following investor
conferences:
-
Canaccord Genuity MedTech, Diagnostics and Digital Health
& Services ForumPresentation: Thursday, November 17,
2022 at 9:30 AM ETWebcast: Click here to
access
- Piper Sandler
34th Annual Healthcare
ConferencePresentation: Wednesday,
November 30, 2022 at 9:30 AM ETWebcast: Click here
to access
Institutional investors interested in meeting
with senior management may contact their respective Canaccord
Genuity or Piper Sandler representative.
A live webcast of both presentations will be
available on the Events page of the Investors section of the
Company’s website at www.mimedx.com or through the conference site
by using the links above. A replay will be available on the
Company’s website following the event.
About MIMEDXMIMEDX is a
transformational placental biologics company, developing and
distributing placental tissue allografts with patent-protected,
proprietary processes for multiple sectors of healthcare. As a
pioneer in placental tissue engineering, we have both a commercial
business, focused on addressing the needs of patients with acute
and chronic non-healing wounds, and a promising late-stage pipeline
targeted at decreasing pain and improving function for patients
with degenerative musculoskeletal conditions. We derive our
products from human placental tissues and process these tissues
using our proprietary methods, including the PURION® process. We
employ Current Good Tissue Practices, Current Good Manufacturing
Practices, and terminal sterilization to produce our allografts.
MIMEDX has supplied over two million allografts, through both
direct and consignment shipments. For additional information,
please visit www.mimedx.com.
Contact:Matt NotarianniInvestor
Relations470-304-7291mnotarianni@mimedx.com
MiMedx (NASDAQ:MDXG)
Gráfico Histórico do Ativo
De Fev 2024 até Mar 2024
MiMedx (NASDAQ:MDXG)
Gráfico Histórico do Ativo
De Mar 2023 até Mar 2024